Unique ID issued by UMIN | UMIN000025974 |
---|---|
Receipt number | R000029857 |
Scientific Title | Anti-fatigue Effects of Yogurt Fermented with Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1. |
Date of disclosure of the study information | 2017/02/02 |
Last modified on | 2018/01/19 14:21:26 |
Anti-fatigue Effects of Yogurt Fermented with Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1.
Anti-fatigue Effects of Yogurt
Anti-fatigue Effects of Yogurt Fermented with Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1.
Anti-fatigue Effects of Yogurt
Japan |
N/A (healthy adults)
Adult |
Others
NO
To evaluate the anti-fatigue effects of yogurt fermented with Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1.
Safety,Efficacy
[1]Autonomic nerve function
[2]Cognitive function
[3]Subjective Fatigue
[1]Condition of sleep
[2]Physical active mass
[3]Fatigue biomarker in blood
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Prevention
Food |
Oral intake of the test food (112 mL) twice a day for 4 weeks.
Washout period for 3 weeks.
Oral intake of the placebo (112mL) twice a day for 4 weeks.
Oral intake of the placebo (112 mL) twice a day for 4 weeks.
Washout period for 3 weeks.
Oral intake of the test food (112mL) twice a day for 4 weeks.
30 | years-old | <= |
60 | years-old | > |
Male and Female
[1]Individuals whose written informed consent has been obtained.
[2]Healthy adults aged 30-59 years.
[1]Individuals under medication or using medial products.
[2]Individuals who have medical history of circulatory system diseases.
[3]Individuals who have autonomic nervous system disorders.
[4]Individuals who have medical history of neurological diseases such as unconsciousness, coma, convulsion, etc.
[5]Individuals who have sleep disorders.
[6]Individuals who have serious diseases such as diabetes, liver diseases, renal diseases, heart diseases.
[7]Individuals who have serious pollinosis.
[8]Individuals who are sensitive to foods or intolerant to lactose.
[9]Individuals who excessively take alcohol(expressed in amount of alcohol: over 60 g/day)
[10]Smokers.
[11]Individuals who have a habit to take fermented milk or lactic acid bacteria beverage two days a week or more in the past 3 months.
[12]Individuals who work the night shift.
[13]Individuals whose BMI is not 17.0-30.9.
[14]Individuals who have meal restrictions.
[15]Women who are pregnant, breastfeeding, or wish to be pregnant in this study period.
[16]Individuals who participated in other clinical trials in the past 1 month or are going to participate in other trials in this study period.
[17]Individuals who are judged not suitable to participate in this trial by investigators.
60
1st name | |
Middle name | |
Last name | Yasuyoshi Watanabe |
Osaka City University
Center for Health Science Innovation
9F, Tower-C, North Building, Grand Front Osaka, 3-1 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan.
+81-6-6485-0288
chsi-b@ado.osaka-cu.ac.jp
1st name | |
Middle name | |
Last name | Mika Furusawa |
Osaka City University
Center for Health Science Innovation
9F, Tower-C, North Building, Grand Front Osaka, 3-1 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan.
+81-6-6485-0288
chsi-b@ado.osaka-cu.ac.jp
Center for Health Science Innovation, Osaka City University
Meiji Co., Ltd.
Profit organization
NO
大阪市立大学健康科学イノベーションセンター(大阪府)
2017 | Year | 02 | Month | 02 | Day |
Unpublished
No longer recruiting
2017 | Year | 02 | Month | 01 | Day |
2017 | Year | 02 | Month | 03 | Day |
2017 | Year | 02 | Month | 02 | Day |
2018 | Year | 01 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029857
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |